Damilola Samuel Ojo-omoniyi

Publishing since 2024, latest 2025

By year

Papers, and the citations to them

Publications, left axisCitations to that year’s papers, right axis2026 still in progress

Citations received each year

Peerford

To all their work, old papers included. Google Scholar also counts citations from theses, books and web pages, so its line runs higher.

From the classification of each paper

Subfields

4 in all

Pharmaceutical Science125%

Public Health, Environmental and Occupational Health125%

Topics most written on

Their most frequent co-authors, and the papers those co-authors share

100% of their papers have a co-author abroad

papers co-written1111222Home

Most frequent partner countries

Papers with at least one author in that country.

Institutions written with most

100% free to read

Nanobiotechnology-driven innovations for tackling antimicrobial resistance
World Journal of Biology Pharmacy and Health Sciences
202514 citationsWorld top 10%Open access · Hybrid
Epigenetic therapies in cancer treatment: Opportunities and challenges
World Journal of Biology Pharmacy and Health Sciences
20242 citationsOpen access · Hybrid
Unraveling tumor microenvironments with spatial genomics: Implications for precision breast cancer therapy
International Journal of Life Science Research Archive
20251 citationOpen access · Hybrid
Biodegradable nanoparticles for targeted drug delivery in viral infections
International Journal of Biological and Pharmaceutical Sciences Archive
20250 citationsOpen access · Hybrid

International Journal of Life Science Research Archive

2025International Journal of Biological and Pharmaceutical Sciences ArchiveJournalOpen access0 citations10.53771/ijbpsa.2025.9.1.0031

2024World Journal of Biology Pharmacy and Health SciencesJournalOpen access2 citations10.30574/wjbphs.2024.20.3.1052